FDA Designates MDMA As 'Breakthrough Therapy' For Post-Traumatic Stress – Forbes
Forbes |
FDA Designates MDMA As ‘Breakthrough Therapy’ For Post-Traumatic Stress
Forbes Following years of lobbying and laboratory research on the medical uses of methylenedioxymethamphetamine, or MDMA, the U.S. Food and Drug Administration has decided to move forward with the drug. Last week, the Multidisciplinary Association for … Psychedelic drug being looked at to treat PTSD FDA Deems MDMA, Banned Since 1985, a ‘Breakthrough Therapy’ FDA Moves Forward on Ecstasy Ingredient Trials for PTSD |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.